X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (216) 216
Publication (37) 37
Conference Proceeding (16) 16
Book Chapter (1) 1
Book Review (1) 1
Magazine Article (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (84) 84
index medicus (69) 69
cancer (67) 67
humans (62) 62
female (54) 54
breast cancer (51) 51
middle aged (38) 38
life sciences (34) 34
aged (33) 33
chemotherapy (33) 33
adult (28) 28
analysis (21) 21
breast neoplasms - pathology (21) 21
[ sdv.can ] life sciences [q-bio]/cancer (19) 19
prognosis (19) 19
carcinoma (17) 17
metastasis (17) 17
survival (17) 17
tumors (17) 17
hematology, oncology and palliative medicine (16) 16
medicine & public health (16) 16
treatment outcome (16) 16
aged, 80 and over (15) 15
breast neoplasms - drug therapy (15) 15
computer science (13) 13
male (13) 13
breast (12) 12
care and treatment (12) 12
france (12) 12
patients (12) 12
therapy (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
cancer patients (11) 11
disease-free survival (11) 11
neoplasm metastasis (11) 11
ovarian cancer (11) 11
solid tumors (11) 11
breast-cancer (10) 10
research (10) 10
resistance (10) 10
trial (10) 10
women (10) 10
expression (9) 9
metabolomics (9) 9
metastatic breast cancer (9) 9
neoplasms - drug therapy (9) 9
survival rate (9) 9
trastuzumab (9) 9
antineoplastic agents - therapeutic use (8) 8
bevacizumab (8) 8
breast neoplasms - mortality (8) 8
cancer therapies (8) 8
combination (8) 8
disease progression (8) 8
endocrine therapy (8) 8
endothelial growth-factor (8) 8
mutation (8) 8
physical activity (8) 8
survival analysis (8) 8
animals (7) 7
breast neoplasms - metabolism (7) 7
cells (7) 7
clinical trials (7) 7
internal medicine (7) 7
nmr (7) 7
ovarian neoplasms - pathology (7) 7
precision medicine (7) 7
radiotherapy (7) 7
tamoxifen (7) 7
algorithms (6) 6
antineoplastic agents (6) 6
biomarkers, tumor - metabolism (6) 6
biomedicine general (6) 6
breast neoplasms - genetics (6) 6
cell line, tumor (6) 6
cohort studies (6) 6
cytotoxic chemotherapy (6) 6
data structures and algorithms (6) 6
exercise (6) 6
follow-up studies (6) 6
immunohistochemistry (6) 6
medical oncology (6) 6
medical prognosis (6) 6
mesh : humans (6) 6
metastases (6) 6
multicenter (6) 6
multivariate analysis (6) 6
neoplasms - pathology (6) 6
paclitaxel (6) 6
prospective studies (6) 6
proteins (6) 6
skin and connective tissue diseases (6) 6
[ info.info-dc ] computer science [cs]/distributed, parallel, and cluster computing [cs.dc] (5) 5
[info.info-ds]computer science [cs]/data structures and algorithms [cs.ds] (5) 5
antimitotic agents (5) 5
cancer du sein (5) 5
diagnosis (5) 5
docetaxel (5) 5
drug resistance, neoplasm (5) 5
estrogen (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Pivot, Xavier and Romieu, Gilles and Debled, Marc and Pierga, Jean-Yves and Kerbrat, Pierre and Bachelot, Thomas and Lortholary, Alain and Espié, Marc and Fumoleau, Pierre and Serin, Daniel and Jacquin, Jean-Philippe and Jouannaud, Christelle and Rios, Maria and Abadie-Lacourtoisie, Sophie and Venat-Bouvet, Laurence and Cany, Laurent and Catala, Stéphanie and Khayat, David and Gambotti, Laetitia and Pauporté, Iris and Faure-Mercier, Celine and Paget-Bailly, Sophie and Henriques, Julie and Grouin, Jean Marie and Piprot, C and Cals, L and Chaigneau, L and Demarchi, F and N'Guyen, T and Stein, U and Villanueva, C and Bréau, JL and Chouahnia, AK and Saintigny, P and Boué, F and deSaint-Hilaire, P and Guimont, I and Grossat, N and Valenza, B and Lévy, E and Médioni, J and Delbaldo, C and Grenier, J and Pouessel, D and Lavau-Denès, S and Falandry, C and Fournel-Fédérico, C and Freyer, G and Tartas, S and Trillet-Lenoir, V and Bons, F and Auclerc, G and Chièze, S and Raban, N and Tournigand, C and Trager-Maury, S and Bousquet, G and Cuvier, C and Giacchetti, S and Hocini, A and LeMaignan, C and Misset, JL and Avenin, D and Beerblock, C and Gligorov, J and Rivera, P and Roché, H and Bougnoux, P and Hajjaji, N and Capitain, O and Delva, R and Maillart, P and Soulié, P and Bonnefoi, H and Durand, M and Madranges, N and Mauriac, L and Chollet, P and Dillies, AF and Durando, X and Ferrière, JP and Mouret-Reynier, C and Nabholtz, JM and Van Praagh, I and Cottu, P and Diéras, V and Durieux, A and Galotte, M and Girre, V and Henry, S and Iurisci, I and Jouve, M and Laurence, V and Mignot, L and Piperno-Neumann, S and Tresca, P and Coudert, B and Ferrant, E and Mayer, F and Vanneuville, AC and ... and PHARE Trial Investigators and PHARE trial investigators
The Lancet, ISSN 0140-6736, 06/2019, Volume 393, Issue 10191, pp. 2591 - 2598
Journal Article
by Coleman, Robert L and Coleman, R L and Oza, Amit M and Oza, A M and Lorusso, D and Lorusso, Domenica and Aghajanian, C and Aghajanian, Carol and Oaknin, A and Oaknin, Ana and Dean, A and Dean, Andrew and Colombo, N and Colombo, Nicoletta and Weberpals, Johanne I and Weberpals, J I and Clamp, Andrew and Clamp, A and Scambia, Giovanni and Scambia, G and Leary, A and Leary, Alexandra and Holloway, Robert W and Holloway, R W and Gancedo, M Amenedo and Gancedo, Margarita Amenedo and Fong, Peter C and Fong, P C and Goh, Jeffrey C and Goh, J C and O'Malley, David M and O'Malley, D M and Armstrong, Deborah K and Armstrong, D K and Garcia-Donas, Jesus and Garcia-Donas, J and Swisher, E M and Swisher, Elizabeth M and Floquet, A and Floquet, Anne and Konecny, Gottfried E and Konecny, G E and McNeish, I A and McNeish, Iain A and Scott, C L and Scott, Clare L and Cameron, Terri and Maloney, Lara and Isaacson, Jeff and Goble, Sandra and Grace, Caroline and Harding, Thomas C and Raponi, Mitch and Sun, James and Lin, Kevin K and Giordano, Heidi and Ledermann, J A and Ledermann, Jonathan A and Buck, M and Friedlander, M L and Harnett, P and Kichenadasse, G and Denys, H and Dirix, L and Vergote, I and Elit, L and Ghatage, P and Plante, M and Provencher, D and Welch, S and Gladieff, L and Joly, F and Lortholary, A and Lotz, J and Medioni, J and Tredan, O and You, B and El-Balat, A and Hänle, C and Krabisch, P and Neunhöffer, T and Pölcher, M and Wimberger, P and Amit, A and Kovel, S and Leviov, M and Safra, T and Shapira-Frommer, R and Stemmer, S and Bologna, A and Pignata, S and Sabbatini, R F and Tamberi, S and Zamagni, C and O'Donnell, A and Herraez, A Casado and Guerra, E M and Palacio, I and Romero, I and Sanchez, A and ... and ARIEL3 Investigators and ARIEL3 investigators
The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10106, pp. 1949 - 1961
Rucaparib, a poly(ADP-ribose) polymerase inhibitor, has anticancer activity in recurrent ovarian carcinoma harbouring a mutation or high percentage of... 
MEDICINE, GENERAL & INTERNAL | MULTICENTER | SOLID TUMORS | BEVACIZUMAB | OPEN-LABEL | CANCER | HETEROZYGOSITY | EPITHELIAL OVARIAN | CHEMOTHERAPY | Double-Blind Method | Follow-Up Studies | Risk Assessment | Humans | Middle Aged | Ovarian Neoplasms - pathology | Neoplasm Recurrence, Local - drug therapy | Survival Rate | Treatment Outcome | Ovarian Neoplasms - mortality | Neoplasm Recurrence, Local - mortality | Indoles - administration & dosage | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Neoplasm Recurrence, Local - pathology | Disease-Free Survival | Maintenance Chemotherapy - methods | Internationality | Ovarian Neoplasms - therapy | Female | Aged | Molecular Targeted Therapy - methods | Clinical trials | Care and treatment | Carcinoma | Drug therapy | Ovarian cancer | Cancer | Analysis | Chemotherapy | Ovarian carcinoma | Platinum | Biomarkers | Mutation | Cancer therapies | Tumors | Homologous recombination | Central nervous system | Poly(ADP-ribose) | Homology | Genomes | Fallopian tube | ADP | Anticancer properties | Metastases | Homologous recombination repair | Randomization | Pain | Motivation | Ribose | Hemoglobin | Alanine | Anemia | Poly(ADP-ribose) polymerase | Breast cancer | Patients | Survival | Heterozygosity | Abdomen | Polymerase | Inhibitors | Point mutation | Loss of heterozygosity | Antitumor activity | Aspartate aminotransferase | Peritoneum
Journal Article
Annals of Oncology, ISSN 0923-7534, 10/2018, Volume 29, Issue suppl_8
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2017, Volume 28, Issue suppl_5
Journal Article
Annals of Oncology, ISSN 0923-7534, 09/2017, Volume 28, Issue suppl_5
Journal Article
Oncogene, ISSN 0950-9232, 07/2012, Volume 31, Issue 30, pp. 3516 - 3524
Overexpression of the ErbB2 receptor tyrosine kinase in breast cancer contributes to tumor development and is associated with poor prognosis. However, the... 
cell migration | ErbB2/Her2 | ST2/IL1RL1 | metastasis | transcriptome | MIGRATION | RESPONSIVE GENE | CANCER CELLS | BIOCHEMISTRY & MOLECULAR BIOLOGY | IL-1 RECEPTOR | INDUCTION | CELL BIOLOGY | INVASION | ONCOLOGY | GENETICS & HEREDITY | ERBB SIGNALING NETWORK | SOLUBLE ST2 PROTEIN | ACTIVATED RECEPTOR-2 | ACUTE EXACERBATION | Interleukin-1 Receptor-Like 1 Protein | Up-Regulation | Peritoneal Neoplasms - blood | Humans | Receptor, ErbB-2 - metabolism | Gene Expression Profiling | Breast Neoplasms - metabolism | Pleural Neoplasms - metabolism | Gene Expression Regulation, Neoplastic - physiology | Carcinoma - secondary | Matrix Metalloproteinases - biosynthesis | Peritoneal Neoplasms - secondary | Pleural Neoplasms - secondary | Carcinoma - blood | Receptors, Cell Surface - metabolism | Receptors, Cell Surface - blood | Breast Neoplasms - pathology | Peritoneal Neoplasms - metabolism | Antibodies, Blocking - immunology | Breast Neoplasms - blood | Cell Line, Tumor | Pleural Neoplasms - blood | Carcinoma - metabolism | Cell Movement | RNA, Small Interfering - metabolism | Receptors, Cell Surface - genetics | Motility | Physiological aspects | Breast cancer | Genetic aspects | Research | Metastasis | Gene expression | Cells | Cell adhesion & migration | Prognosis | Transcription | Tumor cells | Antibodies | Data processing | siRNA | Matrix metalloproteinase | ErbB-2 protein | Metastases | Breast carcinoma | Interleukin 1 | Plasma membranes | Protein-tyrosine kinase receptors | Cell migration | Tumors | Carcinoma | Antibodies, Blocking | Gene Expression Regulation, Neoplastic | Matrix Metalloproteinases | Receptors, Cell Surface | Breast Neoplasms | Life Sciences | Receptor, erbB-2 | Peritoneal Neoplasms | RNA, Small Interfering | Pleural Neoplasms | Cancer
Journal Article